Literature DB >> 2452795

Albumin-negative hepatocytes in Sprague-Dawley x analbuminemic F1 rats treated with hepatic carcinogens.

K Ogawa1, K Yokota, T Sonoda, Z S Piao, M Mori, S Nagase.   

Abstract

Analbuminemic rats (NAR) are a mutant breed with an inherent inability to synthesize albumin. However, heterozygous rats born of a pair of NAR and Sprague-Dawley (SD) rats can synthesize albumin. Immunohistochemical staining for albumin shows that, although the majority of hepatocytes of SD x NAR F1 (female SD x male NAR) rats are positive for albumin, a small number of hepatocytes are negative. These albumin-negative hepatocytes are frequently found in the form of clusters which appear cytologically normal. When the rats were given a dietary regimen of 2-acetyl-aminofluorene (2-AAF), there was a significant increase in the number of albumin-negative hepatocytes. On the other hand, diethylnitrosamine (DEN) or 5-azacytidine did not increase the number of albumin-negative hepatocytes. 2-AAF and DEN also induced enzyme-altered hepatocytes but the albumin-negative hepatocytes were of a completely different class from the enzyme-altered hepatocytes. The results of this study indicate that some kind(s) of carcinogens induce mutated hepatocytes which are probably not involved in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452795     DOI: 10.1002/ijc.2910410515

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  2 in total

1.  Genotypic differentiation of intrahepatically transplanted hyperplastic nodule cells of analbuminemic and normal rat origin by polymerase chain reaction.

Authors:  Y Nishikawa; H Sakai; M Inagaki; I Fukuda; K Ogawa; S Nagase
Journal:  Jpn J Cancer Res       Date:  1990-08

2.  Quantitative comparison of initiation and mutation phenotypes in hepatocytes of the analbuminemic rat.

Authors:  Y P Dragan; C Laufer; A J Koleske; N Drinkwater; H C Pitot
Journal:  Jpn J Cancer Res       Date:  1993-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.